Gsk (GLAXF) Goodwill (2009 - 2026)

Gsk's Goodwill history runs 18 years deep, the most recent figure standing at $9.8 billion for Q1 2026.

• In Q1 2026, Goodwill rose 12.62% year-over-year to $9.8 billion; the TTM figure through Mar 2026 stood at $9.8 billion (up 12.62% YoY), while the FY2025 annual figure was $9.3 billion, up 3.68% from the prior year.
• Goodwill was $9.8 billion for Q1 2026 at Gsk, up from $9.3 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $11.1 billion in Q1 2022 to a low of $7.4 billion in Q2 2022.
• Historically, Goodwill has averaged $8.9 billion across 5 years, with a median of $8.8 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Goodwill slumped 49.01% in 2022, then rose 13.0% in 2023.
• A 5-year view of Goodwill shows it stood at $8.3 billion in 2022, then advanced by 2.29% to $8.5 billion in 2023, then gained by 6.01% to $9.0 billion in 2024, then advanced by 4.17% to $9.3 billion in 2025, then climbed by 5.24% to $9.8 billion in 2026.
• The last three Goodwill figures came in at $9.8 billion (Q1 2026), $9.3 billion (Q4 2025), and $9.6 billion (Q3 2025), per Business Quant data.